Mark Feinberg, MD

Dr. Mark W. Feinberg is a Cardiologist and vascular biologist at Brigham and Women’s Hospital (BWH) and an Associate Professor of Medicine at Harvard Medical School. Dr. Feinberg is Director, Program in Cardiovascular RNA Biology Research that investigates mechanisms leading to the development of a range of macrovascular (e.g. atherosclerosis and coronary and peripheral artery disease) and microvascular disease (e.g. diabetes and wound healing). His group has elucidated the functional role of non-coding RNAs (microRNAs and lncRNAs) in endothelial cells, leukocytes, and vascular smooth muscle cells and has translated these findings into novel therapeutic approaches for ischemic cardiovascular disease states. Dr. Feinberg has held various leadership roles in cardiovascular research including his service on national peer review study sections, editorial service, and as a Co-Chair of the Brigham Research Institute’s Cardiovascular, Diabetes, and Metabolic Disorders Center. Dr. Feinberg completed his Cardiovascular Medicine fellowship training at Brigham and Women’s Hospital, where he subsequently joined the faculty. He serves as Associate Program Director of the BWH Cardiology Fellowship training program. Dr. Feinberg is a member of the American Society of Clinical Investigation and has received several major research awards including an AHA Louis N. and Arnold M. Katz Prize Finalist and the AstraZeneca David W. Haack Memorial Award. Lab Website: http://feinberglab.bwh.harvard.edu